BPG is committed to discovery and dissemination of knowledge
Observational Study
Copyright: ©Author(s) 2026.
World J Methodol. Sep 20, 2026; 16(3): 121596
Published online Sep 20, 2026. doi: 10.5662/wjm.v16.i3.121596
Table 2 Comparisons between subjects without and with periodontitis, n (%)

Subjects without periodontitis (n = 86)
Subjects with periodontitis (n = 57)
P value
Gender female64 (74.4)36 (63.2)0.19
Age (years) - median (P25-P75)35 (20-43)59 (51-68)< 0.001
Arterial hypertension 4 (4.7)17 (29.8)< 0.001
Cardiovascular disease04 (7.0)0.02
Hypercholesterolemia2 (2.3)2 (3.5)0.99
Diabetes mellitus03 (5.3)0.06
Rheumatoid arthritis1 (1.2)3 (5.3)0.30
Metrotexate for rheumatoid arthritis1 (1.2)00.99
Immunosupressive therapy1 (1.2)1 (1.8)0.99
Radiotherapy01 (1.8)0.40
Body mass index (kg/m2) - median (P25-P75)
24.6 (22.4-26.6)24.8 (22.5-27.6)0.66
Obesity11 (12.8)8 (14.0)0.99
Never smoker68 (79.1)25 (43.9)< 0.001
Coffee66 (76.7)50 (87.7)0.13
Tea22 (25.6)3 (5.3)0.001
Alcohol34 (39.5)30 (52.6)0.17
Salivary GPx-1 levels (pg/mL) - median (P25-P75)1511 (887-2024)924 (324-1252)< 0.001
Salivary GPx-1 levels < 1214 pg/mL26 (30.2)42 (73.7)< 0.001


Write to the Help Desk